# Shanghai Jianyi Tengchuang Biomedical Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-jianyi-tengchuang-biomedical-technology

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Latest round: Angel (Aug 11, 2023)
- Investors on record: 1

## About

Founded in 2022 and based in Shanghai, China, Shanghai Jianyi Tengchuang Biomedical Technology operates as a biopharmaceutical company that focuses on the R&D of new drugs for pets. It is a member of Shanghai Minjianghui Pharmaceutical. The company has a branch office in Suzhou. The team members have decades of experience in drug research and development. Zijian Cao, Cao Zijian, the founder of the company, used to engage in strategic planning, business development, and R&D in many multinational companies. In August 2024, Shanghai Jianyi Tengchuang Biomedical Technology closed a strategic investment from new investor Shenlian Biomedical.

The company is mainly engaged in the research and development of innovative pet drugs. It develops innovative pet drugs and complex preparations based on international standards. Its products include patented compounds, 505b2 preparations specifically suitable for pets, and new pet diagnostic reagents.

The company generates revenue by selling innovative pet drugs.

The company will cooperate with Shenlian Biomedical in the fields of pet treatment, prevention, and diagnostic biological products.

## Funding rounds

- Angel, Aug 11, 2023 — Jinding Capital

## Investors

- Jinding Capital (https://capitalatlas.ai/funds/jinding-capital) — Angel